Dr. Michael Joseph Blumenkrantz, MD

Dr. Blumenkrantz practices at Cedars-Sinai Endoscopy in Beverly Hills, California.

Dr. Blumenkrantz's NPI, 1619984234, was assigned on August 3, 2006. Dr. Blumenkrantz graduated from Albert Einstein College of Medicine in 1968. Dr. Blumenkrantz holds California license G17734.

Dr. Blumenkrantz's primary practice is Cedars-Sinai Endoscopy, at 200 N Robertson Blvd, Beverly Hills, CA 90211 in Los Angeles County. The practice phone is (310) 385-3239.

Dr. Blumenkrantz's primary practice is Cedars-Sinai Endoscopy in Beverly Hills, California. Dr. Blumenkrantz is also affiliated with Cedars-Sinai Medical Center. Dmand AI also links Dr. Blumenkrantz to 1 more home health agency, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blumenkrantz practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Blumenkrantz's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Blumenkrantz is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Blumenkrantz's licenses on file in 3 states: California, Florida and Pennsylvania.

Dmand AI lists atrial fibrillation and flutter, chronic anemia, chronic diabetes, chronic hypertension, chronic kidney disease, chronic nasal allergies, coronary artery disease and diabetic emergency among the conditions Dr. Blumenkrantz treats.

CMS data shows 294 Medicare services from Dr. Blumenkrantz across 2 procedure codes in 2024, for 57 Medicare patients. Medicare paid $24,118 for them. Every service was in an office.

CMS counts 57 Medicare patients who saw Dr. Blumenkrantz in 2024. The largest group is 75 to 84, with 24 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Blumenkrantz's median patient age at 77, with 45% women.

In 2024, Dr. Blumenkrantz wrote 1,526 Medicare Part D claims for 71 patients. 74% of them were for generic drugs. CMS names the drug for 1,150 of them, across 42 drugs with 11 or more claims each, at $246,548 in total drug cost. In 2023, CMS named 991 claims across 40 drugs.

Dr. Blumenkrantz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Blumenkrantz.

CMS Open Payments shows 60 general payments to Dr. Blumenkrantz from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 66% of the total. Alexion Pharmaceuticals, Inc. paid the most, $744.

Dr. Blumenkrantz graduated from Albert Einstein College of Medicine in 1968. Dr. Blumenkrantz is a member of ACP.

Dr. Blumenkrantz is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.